INS and fatty liver disease: SREBP-1c, the only SREBP isoform induced by insulin, is transcriptionally induced at mRNA as well as the proteolytically activated by insulin, leading to the induction of hepatic lipogenesis pathway and the development of hepatic steatosis [29].